Increased Affinity and Stability of an Anti-HIV-1 Envelope Immunotoxin by Structure-based Mutagenesis
Open Access
- 1 September 2002
- journal article
- Published by Elsevier BV
- Vol. 277 (37), 34383-34390
- https://doi.org/10.1074/jbc.m205456200
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- The Challenge of Viral Reservoirs in HIV-1 InfectionAnnual Review of Medicine, 2002
- Reservoirs of Human Immunodeficiency Virus Type 1: The Main Obstacles to Viral EradicationClinical Infectious Diseases, 2002
- Reservoirs for HIV Infection and Their Persistence in the Face of Undetectable Viral LoadAIDS Patient Care and STDs, 2001
- Rationale for the Use of Immunotoxins in the Treatment of HIV-infected HumansJournal of Drug Targeting, 1998
- Recombinant Human Monoclonal Antibody IgG1b12 Neutralizes Diverse Human Immunodeficiency Virus Type 1 Primary IsolatesAIDS Research and Human Retroviruses, 1997
- Therapeutic potential of anti-HIV immunotoxinsAntiviral Research, 1996
- Immunotoxins: An UpdateAnnual Review of Immunology, 1996
- CDR Walking Mutagenesis for the Affinity Maturation of a Potent Human Anti-HIV-1 Antibody into the Picomolar RangeJournal of Molecular Biology, 1995
- In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity.Proceedings of the National Academy of Sciences of the United States of America, 1994
- A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.Proceedings of the National Academy of Sciences of the United States of America, 1991